Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth
about
Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonistContribution of toll-like receptor signaling pathways to breast tumorigenesis and treatmentThe Yin and Yang of Toll-like receptors in cancerA conserved TLR5 binding and activation hot spot on flagellinToll-like receptor mediated regulation of breast cancer: a case of mixed blessings.Non-invasive imaging of Toll-like receptor 5 expression using (131)I-labeled mAb in the mice bearing H22 tumorsToll-like receptor-4 signaling in mantle cell lymphoma: effects on tumor growth and immune evasion.Prognostic value of myeloid differentiation primary response 88 and Toll-like receptor 4 in breast cancer patients.Antibodies against Marinobacter algicola and Salmonella typhimurium flagellins do not cross-neutralize TLR5 activationReevaluating the hype: four bacterial metabolites under scrutiny.Toll-like receptor 5 in obesity: the role of gut microbiota and adipose tissue inflammation.Expression of toll-like receptors on breast tumors: taking a toll on tumor microenvironment.Decreased expression of Toll-like receptor 4 and 5 during progression of prostate transformation in transgenic adenocarcinoma of mouse prostate mice.The human TLR innate immune gene family is differentially influenced by DNA stress and p53 status in cancer cells.Toll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8+ T-cell axisToll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue.The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism.TLR agonists: our best frenemy in cancer immunotherapyInteraction between p53 and estradiol pathways in transcriptional responses to chemotherapeutics.Intranasal immunization with a flagellin-adjuvanted peptide anticancer vaccine prevents tumor development by enhancing specific cytotoxic T lymphocyte response in a mouse modelCharacterization of the microbiome of nipple aspirate fluid of breast cancer survivors.Activation of NLRC4 downregulates TLR5-mediated antibody immune responses against flagellin.Application potential of toll-like receptors in cancer immunotherapy: Systematic review.IRAK4 and TLR3 Sequence Variants may Alter Breast Cancer Risk among African-American WomenA flagellin-derived toll-like receptor 5 agonist stimulates cytotoxic lymphocyte-mediated tumor immunityMAP1S controls breast cancer cell TLR5 signaling pathway and promotes TLR5 signaling-based tumor suppression.Understanding the dynamics of Toll-like Receptor 5 response to flagellin and its regulation by estradiol.Mechanisms of therapeutic resistance in cancer (stem) cells with emphasis on thyroid cancer cells.Differential effects of peptidoglycan on colorectal tumors and intestinal tissue post-pelvic radiotherapyPromising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune PathwaysToll-like receptor-5 agonist Entolimod broadens the therapeutic window of 5-fluorouracil by reducing its toxicity to normal tissues in mice.Dysregulation of signaling pathways associated with innate antibacterial immunity in patients with pancreatic cancer.Exogenous or endogenous Toll-like receptor ligands: which is the MVP in tumorigenesis?Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.Toll-like receptor agonists: current status and future perspective on their utility as adjuvants in improving anticancer vaccination strategies.Mutations in components of antiviral or microbial defense as a basis for breast cancer.Utilizing bacterial flagellins against infectious diseases and cancers.Bacterial flagellin-a potent immunomodulatory agent.Toll-like receptors in hepatocellular carcinoma: potential novel targets for pharmacological intervention.Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study.
P2860
Q24623979-91327495-4F97-485C-BFF8-6EF1460BD538Q26825259-58B08087-D1A9-4988-9A8D-A8D8DF916999Q26851526-07396EA6-33C2-4CB9-BC69-C53E72B6B925Q28818682-F2A67FF6-C79F-4EC1-9590-23368C832101Q33658124-C3CBDA83-88BF-4A70-B861-5B3B7E63EE66Q33727715-B6C468BD-7E54-4516-8EB0-6CED271C12C9Q34415459-6FE8F6E4-6549-4C45-BD7D-C08780FD9B8FQ34435221-35993CF9-6CDC-420B-9F4F-D887431E7F5BQ34478993-14A0E496-9AAC-412E-BC8E-AAC34BC2F4A2Q35426826-3747F098-F42D-471F-B227-CB8960D9049EQ35547292-13F2AFC2-FFB5-4EA9-91CE-211C3E4909FFQ35684548-DF5F2B69-F477-4896-A911-6C92F325CD70Q36105484-8D6D6832-D052-4612-B10C-DDEA8A6DD5B2Q36237533-A3A85CD7-3A36-41A4-A863-EE5A2B05F9FAQ36607439-6B07E114-8BF2-47DF-9294-D6C1DA48E495Q36671862-23A75591-FEC2-4DDD-9D3A-ABDD8F869C86Q36771989-62E65E6E-B605-4855-8BA9-D4C9FE8BD989Q36850457-42D85F63-A573-407C-8290-328236744D82Q36906240-540642F6-4BE4-422B-9571-63FAFDDB03EDQ37010997-C560A7B0-4DE3-405E-91C2-E00814F9C656Q37024095-19F81A77-D357-4251-8F72-4CA83391F631Q37101139-E34FA87E-C4BA-465B-82F8-078C757C6BEDQ37205171-EC6DAF02-DAE3-4691-B78A-08AFA915E55CQ37261748-58BBB6DD-167F-4C8A-B1A7-792BBCB57173Q37478775-9CFC1AE5-D7A2-42E1-965D-596F7C2DAFD3Q37510593-8D77B3A8-3681-4B55-BA11-A35341E3CA5AQ37599353-BCD5B9A0-A850-42D2-B0AB-450D5864E6B9Q37676466-A07793B2-54C7-4636-8B51-78B116AC510CQ37689006-BAE6A6B8-9EFD-4BE1-918C-B3E2E82F1674Q37690959-1FE4BA84-F2CB-476E-B3B5-71AE4CC00A93Q37718417-56A5D44A-80D2-4707-9BD4-81BC6877DCE5Q37739809-170A4835-BED0-48B1-9D38-279949800190Q37952071-52BDB90F-DB18-43BA-8190-F04E9051374BQ38039958-A8AC88E3-B7F8-4EF0-B5A3-1C00702CAA1DQ38103581-220551EA-075F-42B8-BB29-7510B7EB7E93Q38140679-5132A2EE-55DE-4657-A240-8F04E8E5071BQ38166277-DEB60CA4-307E-4EE5-9CB5-5A1594D166A1Q38634734-D66C4525-7554-446B-ABA5-08841F581963Q38783106-F4C43859-F572-439A-A6A3-5C0D1F324537Q38879048-0744F655-C6A3-40CE-BF8C-E4067D4EC23D
P2860
Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Activation of Toll-like recept ...... proliferation and tumor growth
@ast
Activation of Toll-like recept ...... proliferation and tumor growth
@en
Activation of Toll-like recept ...... proliferation and tumor growth
@nl
type
label
Activation of Toll-like recept ...... proliferation and tumor growth
@ast
Activation of Toll-like recept ...... proliferation and tumor growth
@en
Activation of Toll-like recept ...... proliferation and tumor growth
@nl
prefLabel
Activation of Toll-like recept ...... proliferation and tumor growth
@ast
Activation of Toll-like recept ...... proliferation and tumor growth
@en
Activation of Toll-like recept ...... proliferation and tumor growth
@nl
P2093
P2860
P3181
P1433
P1476
Activation of Toll-like recept ...... proliferation and tumor growth
@en
P2093
Amir Sanchez
Dekai Zhang
Tingting Zhang
Zhenyu Cai
Zhongcheng Shi
P2860
P304
P3181
P356
10.1158/0008-5472.CAN-10-1993
P407
P50
P577
2011-03-22T00:00:00Z